Erfe is upregulated in erythroid tissues in all conditions characterized by increased serum EPO and expanded erythropoiesis, such as iron deficiency anemia and hypoxia [80], but also in diseases characterized by ineffective erythropoiesis, such as beta-thalassemia [82]. This evidence concerns the gene EPO and anemia.